IL-17 receptor and its functional significance in psoriatic arthritis

Siba P Raychaudhuri, Smriti K. Raychaudhuri, Mark C. Genovese

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

To delineate the functional significance of IL-17 Receptor (IL-17RA) and characterize the IL-17 producing T cell (T h17) subpopulation in psoriatic arthritis (PsA). Mononuclear cells from blood and synovial fluid (SF) were obtained from PsA (n = 20), rheumatoid arthritis (RA, n = 20) and osteoarthritis (OA, n = 20) patients. Synoviocytes (FLS) were isolated from the synovium of RA (n = 5), PsA (n = 5) and OA (n = 5) patients. IL-17RA expression in FLS was identified by western blotting (WB) and flowcytometry. T lymphocytes derived from the SF of these patients were studied to identify and phenotype the T h17 cells. The functional significance of IL-17RA was determined by evaluating its regulatory role on the production of proinflammatory cytokines and endopeptidase. IL-17RA expression was found to be significantly higher in FLS of RA (15.7% ± 4.9) and PsA (4.5% ± 0.9) in comparison to OA (1.14% ± 0.9). Western blot analyses showed that the relative intensity (RI) of IL-17RA protein was higher in RA and PsA compared to OA (Fisher exact, P < 0.01). A significant enrichment of IL-17-producing CD4+ T cells (7.9% ± 2.8) was observed in the SF of PsA patients compared to that of OA patients (P < .001). Compared to OA-FLS, recombinant IL-17 induced higher levels of IL-6, IL-8, and MMP-3 production in PsA-FLS. Blockage of IL-17RA with an anti-IL-17RA antibody inhibited the production of IL-6, IL-8, and MMP-3. This is the first report to demonstrate the functional significance of IL-17RA in PsA. Results of this study support the hypothesis that IL-17RA blocking antibodies have the potential to be a therapeutic option for psoriatic arthritis.

Original languageEnglish (US)
Pages (from-to)419-429
Number of pages11
JournalMolecular and Cellular Biochemistry
Volume359
Issue number1-2
DOIs
StatePublished - Jan 2012

Fingerprint

Interleukin-17 Receptors
Psoriatic Arthritis
T-cells
Interleukin-17
Matrix Metalloproteinases
Interleukin-8
Fluids
Interleukin-6
Endopeptidases
Blocking Antibodies
Synovial Fluid
Blood
Cytokines
T-Lymphocytes
Antibodies
Western Blotting
Proteins
Synovial Membrane
Osteoarthritis
Antibody Formation

Keywords

  • IL-17/IL-17R
  • Psoriasis
  • Psoriatic arthritis
  • Synovial tissue
  • Synoviocytes/FLS
  • T 17 cells

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

IL-17 receptor and its functional significance in psoriatic arthritis. / Raychaudhuri, Siba P; Raychaudhuri, Smriti K.; Genovese, Mark C.

In: Molecular and Cellular Biochemistry, Vol. 359, No. 1-2, 01.2012, p. 419-429.

Research output: Contribution to journalArticle

Raychaudhuri, Siba P ; Raychaudhuri, Smriti K. ; Genovese, Mark C. / IL-17 receptor and its functional significance in psoriatic arthritis. In: Molecular and Cellular Biochemistry. 2012 ; Vol. 359, No. 1-2. pp. 419-429.
@article{1ccacb6609024d009535523f3a13140d,
title = "IL-17 receptor and its functional significance in psoriatic arthritis",
abstract = "To delineate the functional significance of IL-17 Receptor (IL-17RA) and characterize the IL-17 producing T cell (T h17) subpopulation in psoriatic arthritis (PsA). Mononuclear cells from blood and synovial fluid (SF) were obtained from PsA (n = 20), rheumatoid arthritis (RA, n = 20) and osteoarthritis (OA, n = 20) patients. Synoviocytes (FLS) were isolated from the synovium of RA (n = 5), PsA (n = 5) and OA (n = 5) patients. IL-17RA expression in FLS was identified by western blotting (WB) and flowcytometry. T lymphocytes derived from the SF of these patients were studied to identify and phenotype the T h17 cells. The functional significance of IL-17RA was determined by evaluating its regulatory role on the production of proinflammatory cytokines and endopeptidase. IL-17RA expression was found to be significantly higher in FLS of RA (15.7{\%} ± 4.9) and PsA (4.5{\%} ± 0.9) in comparison to OA (1.14{\%} ± 0.9). Western blot analyses showed that the relative intensity (RI) of IL-17RA protein was higher in RA and PsA compared to OA (Fisher exact, P < 0.01). A significant enrichment of IL-17-producing CD4+ T cells (7.9{\%} ± 2.8) was observed in the SF of PsA patients compared to that of OA patients (P < .001). Compared to OA-FLS, recombinant IL-17 induced higher levels of IL-6, IL-8, and MMP-3 production in PsA-FLS. Blockage of IL-17RA with an anti-IL-17RA antibody inhibited the production of IL-6, IL-8, and MMP-3. This is the first report to demonstrate the functional significance of IL-17RA in PsA. Results of this study support the hypothesis that IL-17RA blocking antibodies have the potential to be a therapeutic option for psoriatic arthritis.",
keywords = "IL-17/IL-17R, Psoriasis, Psoriatic arthritis, Synovial tissue, Synoviocytes/FLS, T 17 cells",
author = "Raychaudhuri, {Siba P} and Raychaudhuri, {Smriti K.} and Genovese, {Mark C.}",
year = "2012",
month = "1",
doi = "10.1007/s11010-011-1036-6",
language = "English (US)",
volume = "359",
pages = "419--429",
journal = "Molecular and Cellular Biochemistry",
issn = "0300-8177",
publisher = "Springer Netherlands",
number = "1-2",

}

TY - JOUR

T1 - IL-17 receptor and its functional significance in psoriatic arthritis

AU - Raychaudhuri, Siba P

AU - Raychaudhuri, Smriti K.

AU - Genovese, Mark C.

PY - 2012/1

Y1 - 2012/1

N2 - To delineate the functional significance of IL-17 Receptor (IL-17RA) and characterize the IL-17 producing T cell (T h17) subpopulation in psoriatic arthritis (PsA). Mononuclear cells from blood and synovial fluid (SF) were obtained from PsA (n = 20), rheumatoid arthritis (RA, n = 20) and osteoarthritis (OA, n = 20) patients. Synoviocytes (FLS) were isolated from the synovium of RA (n = 5), PsA (n = 5) and OA (n = 5) patients. IL-17RA expression in FLS was identified by western blotting (WB) and flowcytometry. T lymphocytes derived from the SF of these patients were studied to identify and phenotype the T h17 cells. The functional significance of IL-17RA was determined by evaluating its regulatory role on the production of proinflammatory cytokines and endopeptidase. IL-17RA expression was found to be significantly higher in FLS of RA (15.7% ± 4.9) and PsA (4.5% ± 0.9) in comparison to OA (1.14% ± 0.9). Western blot analyses showed that the relative intensity (RI) of IL-17RA protein was higher in RA and PsA compared to OA (Fisher exact, P < 0.01). A significant enrichment of IL-17-producing CD4+ T cells (7.9% ± 2.8) was observed in the SF of PsA patients compared to that of OA patients (P < .001). Compared to OA-FLS, recombinant IL-17 induced higher levels of IL-6, IL-8, and MMP-3 production in PsA-FLS. Blockage of IL-17RA with an anti-IL-17RA antibody inhibited the production of IL-6, IL-8, and MMP-3. This is the first report to demonstrate the functional significance of IL-17RA in PsA. Results of this study support the hypothesis that IL-17RA blocking antibodies have the potential to be a therapeutic option for psoriatic arthritis.

AB - To delineate the functional significance of IL-17 Receptor (IL-17RA) and characterize the IL-17 producing T cell (T h17) subpopulation in psoriatic arthritis (PsA). Mononuclear cells from blood and synovial fluid (SF) were obtained from PsA (n = 20), rheumatoid arthritis (RA, n = 20) and osteoarthritis (OA, n = 20) patients. Synoviocytes (FLS) were isolated from the synovium of RA (n = 5), PsA (n = 5) and OA (n = 5) patients. IL-17RA expression in FLS was identified by western blotting (WB) and flowcytometry. T lymphocytes derived from the SF of these patients were studied to identify and phenotype the T h17 cells. The functional significance of IL-17RA was determined by evaluating its regulatory role on the production of proinflammatory cytokines and endopeptidase. IL-17RA expression was found to be significantly higher in FLS of RA (15.7% ± 4.9) and PsA (4.5% ± 0.9) in comparison to OA (1.14% ± 0.9). Western blot analyses showed that the relative intensity (RI) of IL-17RA protein was higher in RA and PsA compared to OA (Fisher exact, P < 0.01). A significant enrichment of IL-17-producing CD4+ T cells (7.9% ± 2.8) was observed in the SF of PsA patients compared to that of OA patients (P < .001). Compared to OA-FLS, recombinant IL-17 induced higher levels of IL-6, IL-8, and MMP-3 production in PsA-FLS. Blockage of IL-17RA with an anti-IL-17RA antibody inhibited the production of IL-6, IL-8, and MMP-3. This is the first report to demonstrate the functional significance of IL-17RA in PsA. Results of this study support the hypothesis that IL-17RA blocking antibodies have the potential to be a therapeutic option for psoriatic arthritis.

KW - IL-17/IL-17R

KW - Psoriasis

KW - Psoriatic arthritis

KW - Synovial tissue

KW - Synoviocytes/FLS

KW - T 17 cells

UR - http://www.scopus.com/inward/record.url?scp=83555174764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83555174764&partnerID=8YFLogxK

U2 - 10.1007/s11010-011-1036-6

DO - 10.1007/s11010-011-1036-6

M3 - Article

VL - 359

SP - 419

EP - 429

JO - Molecular and Cellular Biochemistry

JF - Molecular and Cellular Biochemistry

SN - 0300-8177

IS - 1-2

ER -